LQDA Looks 75.0% Undervalued on GF Value™

gurufocus.com · 2026-09-03

On September 03, 2026, Liquidia Corp (NASDAQ: LQDA) announced that its Yutrepia inhalation powder received Fast Track designation from the FDA for the treatment

Read the full story at gurufocus.com →